» Articles » PMID: 15612252

Towards Safer Vectors for the Field Release of Recombinant Bacteria

Overview
Publisher EDP Sciences
Date 2004 Dec 23
PMID 15612252
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The prospect of the deliberate environmental release of genetically manipulated microorganisms has given rise to a great deal of polemic. Amongst the rational scientific concerns are those concerned with the fate of the released bacteria, the fate of the recombinant genes that they carry, the selective pressures acting upon them in different environmental situations and the long term effects on the environment and human health. All recombinant DNA is carried by vectors (plasmids, transposons or bacteriophage or remnants of these). Thus the way in which recombinant constructions are made may itself lead to potential biosafety concerns, irrespective of the host bacterium and the recombinant DNA fragment of primary interest. The purpose of the present review is to assess progress in improved vector design aimed at eliminating risks due to the way recombinant vectors are constructed. Improved vector constructions include the avoidance of the use, or removal, of antibiotic resistance genes, the use of defective transposons rather than plasmids in order to reduce horizontal transfer and the development of conditionally lethal suicide systems. More recently, new site-specific recombination systems have permitted transposon vectors to be manipulated following strain construction, but before environmental release, so that virtually all recombinant DNA not directly involved in the release experiment is eliminated. Such bacteria are thus pseudo-wild type in that they contain no heterologous DNA other than the genes of interest.

Citing Articles

Recombinant Attenuated Vaccine Displaying Regulated Lysis to Confer Biological Containment and Protect Catfish against Edwardsiellosis.

Swain B, Campodonico V, Curtiss 3rd R Vaccines (Basel). 2023; 11(9).

PMID: 37766146 PMC: 10534663. DOI: 10.3390/vaccines11091470.


Multivalent poultry vaccine development using Protein Glycan Coupling Technology.

Mauri M, Sannasiddappa T, Vohra P, Corona-Torres R, Smith A, Chintoan-Uta C Microb Cell Fact. 2021; 20(1):193.

PMID: 34600535 PMC: 8487346. DOI: 10.1186/s12934-021-01682-4.


Advances in the development of Salmonella-based vaccine strategies for protection against Salmonellosis in humans.

Sears K, Galen J, Tennant S J Appl Microbiol. 2021; 131(6):2640-2658.

PMID: 33665941 PMC: 9292744. DOI: 10.1111/jam.15055.


Alternative Strategies for Microbial Remediation of Pollutants via Synthetic Biology.

Jaiswal S, Shukla P Front Microbiol. 2020; 11:808.

PMID: 32508759 PMC: 7249858. DOI: 10.3389/fmicb.2020.00808.


Microbial and Plant-Assisted Bioremediation of Heavy Metal Polluted Environments: A Review.

Bernard Ojuederie O, Babalola O Int J Environ Res Public Health. 2017; 14(12).

PMID: 29207531 PMC: 5750922. DOI: 10.3390/ijerph14121504.